Trial
NCT05960617
Efficacy and Safety of Empagliflozin in GSD-Ib Patients
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborators
—
Condition
Glycogen Storage Disease Type IB
Intervention
Empagliflozin
Why stopped
The study was not initiated because the planned prospective design was no longer feasible in routine clinical practice before participant enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-18